Stay Informed on Key Developments

Investor News and Updates

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

351 - 360of 392 News

March 21, 2018

European Commission conditionally approves Bayer’s proposed acquisition of Monsanto

March 07, 2018

Bayer in exclusive talks with BASF on the sale of vegetable seeds business

February 28, 2018

Fiscal 2017:

Bayer: business at prior-year level - on track with strategy

February 27, 2018

Bayer proposes increased dividend for 2017 of 2.80 euros per share

February 13, 2018

Not intended for U.S. and UK Media

Bayer receives first approval for Eylea® in China

February 12, 2018

Not intended for U.S. and UK Media

New data for aflibercept show prolonged injection intervals

January 16, 2018

Not intended for U.S. or UK Media

FDA report reaffirms safety profile and effectiveness of Bayer’s Xarelto® in routine clinical practice

January 11, 2018

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer sells 10.4 percent stake in Covestro

January 10, 2018

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer further reduces holding in Covestro

December 20, 2017

Not intended for U.S. and UK Media

Bayer announces initiation of rolling submission of new drug application in the U.S. for larotrectinib for the treatment of TRK fusion cancers

Inform Yourself on Special Topics

Investor News and Updates

Control Weeds, Not Farming

Everything You Need to Know About Glyphosate

Managing Glyphosate Litigation

Managing and Mitigating PCB Litigation Risk